[Skip to content]

EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association
EPDA - European Parkinsons Disease Association
REWRITE TOMORROW
.

Frequently asked question (FAQ)

My mother, aged seventy-eight, developed difficulties with her memory and features of parkinsonism – particularly rigidity and slowness at the same time. Can Parkinson’s produce dementia?

Sometimes, Parkinson’s does affect the thinking parts of the brain, and so leads to other kinds of dementia. One type, called cortical dementia with Lewy bodies, has become better understood in recent years, and may account for many of the people who have symptoms of both Parkinson’s and dementia early in the course of the illness. People with this condition are particularly prone to get early side effects such as hallucinations, so the doses of the drugs given may be more cautious. Some patients may respond to the acetylcholinesterase inhibiting drugs more commonly tried in Alzheimer’s disease. These include donepezil (Aricept), galantamine (Reminyl), rivastigmine (Exelon), and memantine (Ebixa). The latter has a slightly different mechanism of action. These drugs are usually prescribed via a memory clinic and patients are assessed carefully as to whether they are suitable and whether they respond.



This FAQ has been taken with permission from "Parkinson's: Answers at Your Fingertips" by Bridget McCall (Published by Class Publishing)
EPDA EPDA EPDA EPDA EPDA EPDA EPDA EPDA